Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review

被引:0
|
作者
Moss, Kasey [1 ]
Gitman, Victor [2 ]
Sanchez, M. Ines Pinto [3 ,4 ]
Oczkowski, Simon [1 ,5 ]
Armstrong, David [4 ,6 ]
Jayakumar, Saumya [7 ,8 ]
Karvellas, Constantine Jason [8 ]
Selzner, Nazia [9 ]
Dionne, Joanna [10 ,11 ]
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada
[3] McMaster Univ, Div Gastroenterol, Dept Med, Hamilton, ON, Canada
[4] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada
[5] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[6] McMaster Univ, Div Gastroenterol, Dept Med, Hamilton, ON, Canada
[7] Univ British Columbia, Div Gastroenterol, Dept Med, Vancouver, BC, Canada
[8] Univ Alberta, Div Gastroenterol, Dept Med, Edmonton, AB, Canada
[9] Univ Toronto, Div Gastroenterol, Dept Med, Toronto, ON, Canada
[10] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Dept Med, Hamilton, ON, Canada
[11] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Med, Hamilton, ON, Canada
来源
BMJ OPEN | 2024年 / 14卷 / 04期
关键词
Gastroenterology; NUTRITION & DIETETICS; Hepatology; Obesity; HEPATIC STEATOSIS; INDIVIDUALS; PREVALENCE; RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Metabolic dysfunction-associated fatty liver disease (MASLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease worldwide. Given that there is no pharmacological treatment for MASLD, it is imperative to understand whether lifestyle modifications may improve biochemical and pathological outcomes. One commonly proposed dietary modification is the Mediterranean diet; however, vegetarianism may also be a promising intervention. Vegetarianism has been shown to be associated with reduced morbidity and mortality in metabolic syndrome outcomes in coronary artery disease and diabetes; however, the relationship between vegetarian diet and MASLD is less clear. In this scoping review, we will provide a comprehensive overview of the current body of evidence related to a vegetarian diet and MASLD. Methods and analysis The aim of this scoping review is to describe and summarise the current body of evidence related to MASLD and a vegetarian diet. This review will be conducted using Arksey and O'Malley's framework. The literature review will be conducted using the following databases: SCOPUS, Web of Science, CINAHL-Plus, Cochrane Library and Medline. No restriction will be made on publication date. Included studies will encompass clinical trials and observational designs that examine effects or association of vegetarian diet in adults (>= 16 years) and report on the incidence, prevalence or progression of MASLD. Grey literature, non-human studies and articles focusing on changes in a specific food or nutraceutical will be excluded. Articles must have an English-language abstract available to be considered for inclusion. Screening and data extraction will be conducted by two independent reviewers. The findings will be summarised with descriptive statistics. Ethics and dissemination Approval from a medical ethics committee is not required for this review. Once the review is complete, the findings will be submitted to a peer-reviewed journal.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Scarpellini, Emidio
    Scarcella, Marialaura
    Tack, Jan F.
    Scarlata, Giuseppe Guido Maria
    Zanetti, Michela
    Abenavoli, Ludovico
    ANTIOXIDANTS, 2024, 13 (11)
  • [22] Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
    Cherubini, Alessandro
    Della Torre, Sara
    Pelusi, Serena
    Valenti, Luca
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (12) : 1126 - 1136
  • [23] Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease
    Li, Yamei
    Qi, Ping
    Song, Si -Yuan
    Wang, Yiping
    Wang, Hailian
    Cao, Peng
    Liu, Yu 'e
    Wang, Yi
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [24] Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs
    Zhu, Baoqiang
    Wei, Yuankui
    Zhang, Mingming
    Yang, Shiyu
    Tong, Rongsheng
    Li, Wenyuan
    Long, Enwu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [25] Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects
    Moller, Soren
    Kimer, Nina
    Hove, Jens Dahlgaard
    Barlose, Mads
    Gluud, Lise Lotte
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025,
  • [26] Significant nocturnal wakefulness after sleep onset in metabolic dysfunction-associated steatotic liver disease
    Schaeffer, Sofia
    Bogdanovic, Andrijana
    Hildebrandt, Talitha
    Flint, Emilio
    Geng, Anne
    Pecenko, Sylvia
    Lussier, Paul
    Strumberger, Michael A.
    Meyer, Martin
    Weber, Jakob
    Heim, Markus H.
    Cajochen, Christian
    Bernsmeier, Christine
    FRONTIERS IN NETWORK PHYSIOLOGY, 2024, 4
  • [27] Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD: Jordan's Perspective Based on Knowledge and Attitude Determinants
    Alqudah, Omar
    Alshahwan, Hamzeh Feras
    Alsamhouri, Jehad Feras
    Yamin, Saif
    Kaffaf, Ahmad
    Alassaf, Mohannad
    Alwarawrah, Zaid
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2024, 17 : 2483 - 2491
  • [28] Higher Adherence to the Mediterranean Diet Is Associated with a Lower Risk of Steatotic, Alcohol-Related, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Analysis
    Lee, Ji Yae
    Kim, Sue
    Lee, Yaeji
    Kwon, Yu-Jin
    Lee, Ji-Won
    NUTRIENTS, 2024, 16 (20)
  • [29] The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
    Sawada, Keisuke
    Chung, Hak
    Softic, Samir
    Moreno-Fernandez, Maria E.
    Divanovic, Senad
    CELL METABOLISM, 2023, 35 (11) : 1852 - 1871
  • [30] Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease
    Gulati, Reeti
    Moylan, Cynthia A.
    Wilder, Julius
    Wegermann, Kara
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (02):